These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4299576)

  • 21. Poly-beta-hydroxybutyrate-type (PHB) inclusions in B. pertussis and their possible implication in toxicity.
    Ionescu MD; Petrovici A; Andreescu V; Mihai G; Burghelea B; Marion M; Ivan I
    Arch Roum Pathol Exp Microbiol; 1983; 42(4):297-303. PubMed ID: 6087770
    [No Abstract]   [Full Text] [Related]  

  • 22. Estimation of bacterial mass of pertussis vaccine by opacity and dry weight determinations.
    Csizér Z; Szammet A; Niedermayer N; Zsidai F; Auber E; Foó I
    J Biol Stand; 1977; 5(4):289-95. PubMed ID: 200630
    [No Abstract]   [Full Text] [Related]  

  • 23. Pertussis antigens--screening models on toxicity.
    Ronneberger H; Blackkolb F; Guthöhrlein G
    Arch Toxicol Suppl; 1982; 5():129-32. PubMed ID: 6285854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On a possible new kind of toxic substance produced by Bordetella pertussis.
    Kurokawa M; Iwasa S; Ishida S
    Jpn J Med Sci Biol; 1965 Jun; 18(3):161-5. PubMed ID: 5294929
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunochemical studies on the lipopolysaccharides of Bordetella pertussis.
    Aprile MA; Wardlaw AC
    Can J Microbiol; 1973 Feb; 19(2):231-9. PubMed ID: 4121314
    [No Abstract]   [Full Text] [Related]  

  • 26. [My involvement with pertussis vaccines--toxicity of pertussis vaccines and their toxicity tests].
    Kurokawa M
    Nihon Saikingaku Zasshi; 1983 May; 38(3):631-6. PubMed ID: 6655874
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 28. Glutaraldehyde in whole-cell Bordetella pertussis vaccine.
    Arya SC; Ashraf SJ; Pathak VP
    Vaccine; 1989 Dec; 7(6):486. PubMed ID: 2514517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A study of toxic substances in pertussis cultures].
    Malivanova OM
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Nov; (11):93-7. PubMed ID: 188276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of Bordetella pertussis in the Ribi cell fractionator. 2. Effect of different suspending media.
    Hollinger E; Wardlaw AC
    Can J Microbiol; 1971 Sep; 17(9):1195-202. PubMed ID: 4107161
    [No Abstract]   [Full Text] [Related]  

  • 31. Estimation of the bacterial content of pertussis vaccines by dry weight and nitrogen determinations of bacterial mass.
    Csizér Z; Niedermayer N; Szammet A; Zsidai J
    J Biol Stand; 1982 Oct; 10(4):269-72. PubMed ID: 6296154
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on lymphocytosis induced by Hemophilus pertussis. II. Hematological-histochemical observations in experimental animals.
    Fujii K
    Hiroshima J Med Sci; 1968 Dec; 17(4):243-60. PubMed ID: 4307308
    [No Abstract]   [Full Text] [Related]  

  • 33. Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos.
    Calver GA
    Biologicals; 1999 Jun; 27(2):143-7. PubMed ID: 10600203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation from Bordetella pertussis of protective antigen free from toxic activity and histamine sensitizing factor.
    Nagel J
    Nature; 1967 Apr; 214(5083):96-7. PubMed ID: 4291816
    [No Abstract]   [Full Text] [Related]  

  • 35. Reducing the endotoxic activity of pertussis vaccine.
    Bannatyne RM; Cheung R
    J Hyg (Lond); 1981 Dec; 87(3):377-81. PubMed ID: 7310121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Toxicity of Bordetella pertussis suspensions associated with the preparation of pertussis vaccine].
    Raĭkher LI; Kalinina ES; Shafran MI; Khazina EKh; Aĭnbinder ZTs
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):15-7. PubMed ID: 6303021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of toxicities of acellular pertussis vaccine with whole cell pertussis vaccine in experimental animals.
    Sato Y; Sato H
    Dev Biol Stand; 1991; 73():251-62. PubMed ID: 1778317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effectiveness of an endotoxin-depleted pertussis vaccine.
    Bannatyne RM; Jackowski J
    Vaccine; 1987 Dec; 5(4):268-9. PubMed ID: 3433915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. II. The effect of pertussis vaccine on the thoracic duct lymph and lymphocytes of mice.
    Morse SI; Riester SK
    J Exp Med; 1967 Apr; 125(4):619-28. PubMed ID: 4289740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STUDIES ON THE LYMPHOCYTOSIS INDUCED IN MICE BY BORDETELLA PERTUSSIS.
    MORSE SI
    J Exp Med; 1965 Jan; 121(1):49-68. PubMed ID: 14253487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.